Mirae Asset Global Etfs Holdings Ltd. X Biotech Inc. Transaction History

Mirae Asset Global Etfs Holdings Ltd.

  • $56.2 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$2.99 - $4.48 $1,444 - $2,163
483 Added 4.24%
11,873 $38,000
Q4 2024

Feb 14, 2025
BUY
$3.8 - $8.25 $4,696 - $10,197
1,236 Added 12.17%
11,390 $44,000
Q3 2024

Nov 14, 2024
BUY
$5.55 - $7.95 $56,354 - $80,724
10,154 New
10,154 $78,000

Others Institutions Holding XBIT

# of Institutions
48
Shares Held
4.02M
Call Options Held
0
Put Options Held
0
View Full List

About XBiotech Inc.

XBIT Quotes by TradingView
  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $79.8M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email